Unlike disposable e-cigarette, Vape Pod System is designed with vape device and disposable vape pod, which is detachable. Usually latest pod system includes one vape battery device and 3 pods(2ml), magnetic connector between pod and device, 1s pop in.
The processing technology for pod system has been greatly upgraded, the shell adopts oxidation and radium carving technology. The drip tip is made of PCTG food grade material. Moreover the e-cigarette pod system is designed under principle of ergonomics, so that you can feel comfortable, exact fitting when hold and inhale
The e-cigarette is available in dark gray, purple, blue, pink colors, with black electronic cigarette holder, environmentally friendly and full of youthful.
350mAh battery, charged by typc-c, 2ml e juice prefilled, enjoy happy vape all day long.
The M2 e-cigarette kit adopts triple oil leakage prevention design: top and bottom have multiple silica gel, used for rapid absorption of condensate; The middle layer uses the third generation of high density impervious ceramic coil, so that prevent oil leaking from atomizer
Multiple flavors available, apple ice, orange ice, tobacco, grape...... more than 13 fruits choice; 3.0 ceramic atomizing technology provides not only big vapor, but also smooth and delicate taste.
Vape Pod,Vape Pen Disposable,Vape Flavour,Vape Kits,Liquid Vape Shenzhen Axiswell Technology Co., Ltd , https://www.medhealthycare.com
Because tumor cells secrete the stimulatory neurotransmitter glutamate, epilepsy often occurs in patients with gliomas. The survival of glioma requires the presence of the amino acid cystine. When the cystine-glutamate transporter on the tumor delivers cystine to tumor cells, the tumor is also secreted around the nearby brain tissue. A large amount of glutamate esters cause neurons in the vicinity of the tumor to become overactive and seizures occur.
Sulfasalazine is a cystine-glutamate transporter inhibitor approved by the Food and Drug Administration (FDA) for the treatment of patients with intestinal inflammation. Harald Sontheimer and colleagues used sulfasalazine in tumor-bearing mice and found that this drug can prevent the elevation of brain glutamate levels that cause tumors, and it can also reduce glioma-induced seizures in mice. These new findings indicate that it is hopeful to develop new treatments to reduce seizures caused by human brain tumors.
Preventing cystine-glutamate fat transporters to reduce epilepsy
The researchers found that blocking the cystine-glutamate fat transporter can reduce glioma-induced seizures in mice, and the new results were published in the online journal Nature-Medical.